Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Gastroenterologia Y Hepatologia|August 17, 2021
Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programmeAna Santos Lucio, Isabel Rodríguez Tirado, Ana Aparicio Serrano, et al.
Iscience|July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerSusan Halabi, Qian Yang, Akash Roy, et al.
Iscience|June 24, 2022
The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trialDavid C Smith, Matthew R Smith, Christopher Sweeney, et al.
JCO Oncology Practice|November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone TherapyNeha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
Clinical Genitourinary Cancer|July 18, 2020
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate CancerNicholas Spetsieris, Myrto Boukovala, Justin A Weldon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate CancerTomasz M Beer, Eugene D Kwon, Charles G Drake, et al.
Iscience|June 11, 2020
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder CancerGuoliang Yang, Jolanta Bondaruk, David Cogdell, et al.
Pageof 20